SCHEMBL9920737

SCHEMBL9920737

Cc1ccc(-c2ccc3ccc4c(-c5cc(C)c(-n6c7ccccc7c7ccccc76)cc5C)ccc5ccc2c3c54)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.33
COMT P21964 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
MCL1 Q07820 1/20 0.31
BAD Q92934 1/20 0.31
ALDH1A1 P00352 4/20 0.31
FLT3 P36888 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
ACHE P22303 2/20 0.31
ERBB2 P04626 1/20 0.31
CYP1A2 P05177 1/20 0.31
FYN P06241 1/20 0.31
MAOA P21397 1/20 0.31
AHR P35869 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.30
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9920756 0.88 ALDH1A1 (0.36) MAPTCOMTLMNAHTTMCL1
SCHEMBL9920753 0.84 KDM4E (0.34) MAPTCOMTLMNAHTTMCL1
SCHEMBL9920749 0.84 MAPT (0.35) MAPTCOMTLMNAHTTMCL1
SCHEMBL9920942 0.84 MAPT (0.35) MAPTCOMTLMNAHTTMCL1
SCHEMBL9928637 0.82 KDM4E (0.37) MAPTCOMTLMNAHTTALDH1A1
SCHEMBL9920827 0.81 L3MBTL1 (0.36) MAPTCOMTLMNAHTTALDH1A1
SCHEMBL9921080 0.81 L3MBTL1 (0.43) MAPTCOMTLMNAHTTALDH1A1
SCHEMBL9920625 0.81 L3MBTL1 (0.43) MAPTCOMTLMNAHTTALDH1A1
SCHEMBL12938562 0.80 KDM4E (0.38) MAPTLMNAHTTALDH1A1FLT3
SCHEMBL9921089 0.80 KDM4E (0.37) MAPTCOMTLMNAHTTMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463352-B1 Light emitting device material and light emitting device TORAY INDUSTRIES (JP) 2018-05-02 EP disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
EP-2463351-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
EP-2463352-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
EP-1942171-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 MAPT 3173/4885COMT 3633/4885LMNA 1946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.